articleFrontiers in OncologyApr 10, 2024GOLD OA

Lipid-based nanoparticles as drug delivery carriers for cancer therapy

Yangzhou University · Hong Kong Polytechnic University · +3 more institutions

PubMed
Indexed incrossrefdoajpubmed

Abstract

Cancer is a severe disease that results in death in all countries of the world. A nano-based drug delivery approach is the best alternative, directly targeting cancer tumor cells with improved drug cellular uptake. Different types of nanoparticle-based drug carriers are advanced for the treatment of cancer, and to increase the therapeutic effectiveness and safety of cancer therapy, many substances have been looked into as drug carriers. Lipid-based nanoparticles (LBNPs) have significantly attracted interest recently. These natural biomolecules that alternate to other polymers are frequently recycled in medicine due to their amphipathic properties. Lipid nanoparticles typically provide a variety of benefits,…

Citation impact

130
total citations
FWCI
20.40
Percentile
100%
References
183
Citations per year

Authors

6

Topics & keywords

Keywords
  • Drug delivery
  • Biocompatibility
  • Cancer
  • Drug
  • Drug carrier
  • Nanotechnology
  • Cancer therapy
  • Nanomedicine
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding